acadia and neuren about a month ago updated the patent covering the composition of trofinetide for Rett to make it more available in large quantities and cheaper to produce. it has nothing to do with substance. This is in line with growing demand estimates and preparations for the global launch with Canada leading the way. everything else that is suspected has already sunk into ridiculousness.
Ann: Comment on research report, page-208
-
- There are more pages in this discussion • 109 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Add NEU (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
$20.05 |
Change
0.065(0.33%) |
Mkt cap ! $2.563B | |||
| Open | High | Low | Value | Volume |
| $20.11 | $20.14 | $19.63 | $3.009M | 150.6K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 1 | 16 | $20.03 |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| $20.04 | 151 | 5 |
View Market Depth
| Last trade - 11.31am 25/06/2024 (20 minute delay) ? |
| NEU (ASX) Chart |